N@N

Eclipsys Reports Inducement Grants under NASDAQ Marketplace Rule 4350

^{Published on 2009-01-14 14:56:06, Last Modified on 2009-01-14 14:56:37 - Market Wire}
 

ATLANTA--([ BUSINESS WIRE ])--Eclipsys Corporation^® (NASDAQ:ECLP), The Outcomes Company^®, has announced that as an employment inducement following the close of its recent acquisition of Premise Corporation, it will issue to certain Premise personnel a total of 64,832 shares of Eclipsys common stock; and non-qualified options to purchase a total of 270,138 shares of common stock.

All of the common stock is subject to contractual restrictions on transfer until vested: 25 percent of the total number of shares shall vest December 1, 2009, December 1, 2010, December 1, 2011, and December 1, 2012, in each case contingent upon continued employment, with partial pro-rata vesting for time served if employment is terminated by the employee with good reason, or by Eclipsys without cause. The stock options have a seven-year term, an exercise price per share equal to the fair market value of Eclipsys common stock on the date of grant, and vest over four years, contingent upon continued employment, with partial pro-rata vesting for time served if employment is terminated by the employee with good reason or by Eclipsys without cause. These awards are made as inducement grants pursuant to Section 4350(i)(1)(A)(iv) of the NASD Marketplace Rules.

About Eclipsys

Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and performance management software, clinical content and professional services that help healthcare organizations improve clinical, financial and operational outcomes. For more information, see [ www.eclipsys.com ] or email [ info@eclipsys.com ].

Eclipsys Corporation and The Outcomes Company are registered trademarks of Eclipsys Corporation.